The Combination Very Low-Dose Naltrexone–Clonidine in the Management of Opioid Withdrawal

By Mannelli Paolo   Peindl Kathleen   Wu Li-Tzy   Patkar Ashwin A.   Gorelick David A.  

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 3, 2012-05 ,pp. : 200-205

Informa Healthcare

Access to resources Recommend Favorite

Chronic opioid antagonist treatment dose-dependently regulates -opioid receptors and trafficking proteins in vivo

By Rajashekara V.   Patel C.N.   Patel K.   Purohit V.   Yoburn B.C.  

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 4, 2003-07 ,pp. : 909-913

Elsevier

Access to resources Recommend Favorite

 2-Adrenoceptor Antagonist SL84.0418 Involvement in the Development of Opioid Withdrawal

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 2, 2009-03 ,pp. : 159-162

Bentham Science Publishers

Access to resources Recommend Favorite

Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats

By Gallate Jason   Mallet Paul   McGregor Iain  

Psychopharmacology, Vol. 173, Iss. 1-2, 2004-04 ,pp. : 210-216

Springer Publishing Company

Access to resources Recommend Favorite

A Chart Review Comparing Paregoric to Methadone in the Treatment of Neonatal Opioid Withdrawal

By Wunsch Martha J.  

Journal of Addictive Diseases, Vol. 25, Iss. 3, 2006-08 ,pp. : 27-33

Haworth Press

Access to resources Recommend Favorite